Mechanism of action of theophylline in bronchial asthma is
**Core Concept**
Theophylline is a methylxanthine derivative used in the management of bronchial asthma. It works by inhibiting phosphodiesterase (PDE) enzymes, which are involved in the regulation of intracellular cyclic adenosine monophosphate (cAMP) levels.
**Why the Correct Answer is Right**
Theophylline exerts its bronchodilatory effects by increasing the concentration of cAMP in airway smooth muscle cells. This is achieved through the inhibition of PDE3 and PDE4 enzymes, which break down cAMP. Elevated cAMP levels activate protein kinase A (PKA), leading to the relaxation of airway smooth muscle and bronchodilation. Additionally, theophylline has adenosine receptor antagonist properties, which contribute to its bronchodilatory effects.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because theophylline does not work primarily through the inhibition of histone deacetylases (HDACs) or the activation of histone acetyltransferases (HATs). While epigenetic modifications play a role in the regulation of gene expression, they are not directly involved in the mechanism of action of theophylline.
**Option B:** This option is incorrect because theophylline does not work primarily through the inhibition of nitric oxide synthase (NOS) enzymes. Nitric oxide (NO) is a vasodilator that plays a role in the regulation of vascular tone, but it is not directly involved in the mechanism of action of theophylline.
**Option C:** This option is incorrect because theophylline does not work primarily through the activation of beta-2 adrenergic receptors. Beta-2 agonists, such as salbutamol, work by stimulating these receptors to produce bronchodilation, but theophylline works through a different mechanism.
**Option D:** This option is incorrect because theophylline does not work primarily through the inhibition of cyclooxygenase (COX) enzymes. COX inhibitors, such as NSAIDs, work by reducing the production of prostaglandins, which are involved in inflammation and pain, but they are not directly involved in the mechanism of action of theophylline.
**Clinical Pearl / High-Yield Fact**
Theophylline is a narrow therapeutic index medication, and its plasma levels should be monitored carefully to avoid toxicity. A plasma level of 10-20 μg/mL is generally considered therapeutic, while levels above 20 μg/mL can increase the risk of toxicity.
**Correct Answer: C. Inhibition of phosphodiesterase (PDE) enzymes.**